A new Israeli clinical trial is testing a tuberculosis vaccine to prevent Alzheimers - opinion
| TNBAX Fund | USD 19.80 0.08 0.41% |
Slightly above 53% of 1290 Smartbeta's investor base is interested to short. The analysis of overall sentiment of trading 1290 Smartbeta Equity mutual fund suggests that many investors are impartial at this time. 1290 Smartbeta's investing sentiment can be driven by a variety of factors including economic data, 1290 Smartbeta's earnings reports, geopolitical events, and overall market trends.
1290 |
If God forbid I show the biomarkers associated with the probable development of Alzheimers, I will receive three doses of the vaccine, which has minimal side effects.
Read at jpost.com
 |
1290 Smartbeta Fundamental Analysis
We analyze 1290 Smartbeta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 1290 Smartbeta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 1290 Smartbeta based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
1290 Smartbeta is rated fifth largest fund in last dividend paid among similar funds. Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
1290 Smartbeta Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 1290 Smartbeta mutual fund to make a market-neutral strategy. Peer analysis of 1290 Smartbeta could also be used in its relative valuation, which is a method of valuing 1290 Smartbeta by comparing valuation metrics with similar companies.
Peers
1290 Smartbeta Related Equities
| ESCFX | 1290 Funds | 1.75 | ||||
| TNBAX | 1290 Smartbeta | 0.41 | ||||
| TNIIX | 1290 Retirement | 0.27 | ||||
| TNHIX | 1290 High | 0.12 | ||||
| TNHAX | 1290 High | 0.12 | ||||
| TNBCX | 1290 Smartbeta | 0.00 | ||||
| ESCJX | 1290 Essex | 1.71 | ||||
| ESCKX | 1290 Funds | 1.73 |
Other Information on Investing in 1290 Mutual Fund
1290 Smartbeta financial ratios help investors to determine whether 1290 Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 1290 with respect to the benefits of owning 1290 Smartbeta security.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |